https://www.cellectis.com/en/press/cellectis-to-present-clinical-data-on-lasme-cel-and-eti-cel-at-eha-2026-annual-congress/ 2026-06-16T03:02:34+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.webp https://www.cellectis.com/fr/presse/cellectis-publiera-ses-resultats-financiers-du-deuxieme-trimestre-jeudi-6-aout-2026-2026/ 2026-07-30T18:30:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/event-report-individual-shareholders-meeting-held-on-october-23-2014/ 2026-08-06T09:31:55+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/talentm-technology-grant-of-ep-2-510-096-by-the-european-patent-office/ 2026-08-06T09:31:55+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-received-proceeds-of-13-million-through-the-exercise-of-warrants/ 2026-08-06T09:31:55+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-upcoming-presentations-at-the-56th-annual-meeting-of-the-american-society-of-hematology-ash/ 2026-08-06T09:31:55+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-plant-sciences-and-two-blades-foundation-announce-the-execution-of-a-cross-license-agreement-on-tal-effector-nuclease-technologies/ 2026-08-06T09:31:55+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-the-issuance-by-the-uspto-of-a-patent-covering-a-seminal-nuclease-based-gene-editing-method/ 2026-08-06T09:31:55+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-plans-to-conduct-registered-initial-public-offering-in-the-u-s/ 2026-08-06T09:31:55+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-and-the-ohio-state-university-through-the-ohio-state-innovation-foundation-enter-into-licensing-agreement-for-chimeric-antigen-receptor-technology-targeting-multiple-myeloma/ 2026-08-06T09:31:55+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/event-report-cellectis-rd-analyst-day/ 2026-08-06T09:31:55+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-first-half-2014-financial-results/ 2026-08-06T09:31:55+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-2nd-quarter-and-first-half-year-2016-financial-results/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-a-presente-des-resultats-inedits-dans-la-lutte-contre-le-cancer-lors-du-congres-esgct/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-wins-2016-most-innovative-european-biotech-sme-award-for-healthca/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-etend-son-portefeuille-de-propriete-intellectuelle-luniversite-de-liowa-accorde-a-cellectis-deux-licences-exclusives-sur-la-technologie-tal/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-hosts-worlds-first-gene-edited-dinner-in-nyc/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-bioresearch-inc-remporte-un-contrat-portant-sur-69-millions-de-dollars-aupres-du-national-institute-of-health-pour-produire-des-cellules-ips/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-successful-cgmp-manufacturing-for-second-product-candid/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-bioresearch-inc-remporte-un-contrat-aupres-du-national-institutes-of-health-lun-des-plus-prestigieux-centres-de-recherche-au-monde-pour-produire-des-cellules-ips/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-participate-in-oppenheimer-life-sciences-summit-ny-in-piper-jaffray-28th-annual-health-care-conference-ny/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-lattribution-du-prix-nobel-de-medecine-au-professeur-yamanaka-confirme-la-pertinence-de-la-strategie-du-groupe-en-matiere-de-cellules-souches/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-recombinant-dna-advisory-committees-rac-unanimous-approval-of-ucart123-phase-1-study-protocols-in-aml-and-bpdcn/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/medicago-et-cellectis-menent-a-bien-la-premiere-etape-de-leur-collaboration-de-recherche-des-progres-pour-la-production-de-produits-biosimilaires-a-partir-de-plants-de-tabac/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-conference-call-to-discuss-recent-recombinant-dna-advisory-committee-rac-meeting/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-des-resultats-ouvrant-de-nouvelles-perspectives-therapeutiques-pour-la-lutte-contre-le-cancer-et-les-maladies-genetiques/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-submits-ind-application-for-ucart123-an-allogeneic-gene-edited-car-t-cell-product-candidate-in-aml-and-bpdcn/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-stem-cells-annonce-aujourdhui-la-commercialisation-dune-version-amelioree-dun-produit-de-type-cardiomyocyte-issu-de-cellules-souches/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-and-mabquest-announce-immunotherapy-partnership-on-new-class-of-pd-1-antagonist-monoclonal-antibodies/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-at-the-35th-annual-j-p-morgan-healthcare-conference-o/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-resultats-du-premier-semestre-2012/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-retronectin-supply-and-license-agreement-with-takara-bi/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-studies-safety-in-new-car-architecture-controlling-car-t-cell-fun/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-des-progres-dans-le-developpement-dune-nouvelle-approche-therapeutique-du-sida-nature-methods-publie-les-resultats-obtenus-par-cellectis-faisant-etat-dune-avancee-significative-dans-le-doma/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-data-on-its-allogeneic-car-t-cell-programs-at-the-19th-american-society-of-gene-cell-therapy-annual-meeting/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/four-prominent-physicians-to-join-cellectis-clinical-advisory-board/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/assemblee-generale-mixte-des-actionnaires-de-cellectis-du-22-juin-2012/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-first-quarter-2016-financial-results/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-at-the-american-society-of-gene-cell-therapy-annual-meeting/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-a-reussi-a-editer-le-genome-dalgues-photosynthetiques-dans-le-but-de-leur-faire-produire-des-biocarburants/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-to-present-at-the-2017-annual-conference-of-the-american-association-for-cancer-research/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-s-a-reports-results-from-shareholders-general-meeting-held-on-ma/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-met-en-place-une-ligne-pluriannuelle-de-financement-en-fonds-prop/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-to-present-data-on-its-allogeneic-car-t-cell-programs-at-the-20th-american-society-of-gene-cell-therapy-annual-meeting-en/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-first-patient-treated-in-phase-1-trial-of-ucart19-in-pediatric-acute-b-lymphoblastic-leukemia-b-all/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-une-approche-anti-cancer-innovante-cellectis-a-signe-avec-le-college-universitaire-de-londres-ucl-un-accord-de-collaboration-pour-developper-un-programme-therapeutique-pour-lutter-contre-la/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-named-2016-technology-pioneer-by-the-world-economic-forum/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/le-pr-shinya-yamanaka-prix-nobel-de-medecine-2012-reaffirme-son-attachement-a-la-cooperation-du-cira-avec-le-groupe-cellectis/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/mit-technology-review-names-cellectis-on-annual-list-of-50-smartest-companies-for-second-consecutive-year/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/le-premier-ministre-jean-marc-ayrault-accompagne-de-madame-fleur-pellerin-ministre-deleguee-aupres-du-ministre-du-redressement-productif-a-visite-ce-vendredi-9-novembre-2012-la-plate-forme-industriell/ 2026-08-06T09:31:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-has-successfully-engineered-the-genome-of-photosynthetic-algae-with-a-view-to-biofuel-production/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-plant-sciences-and-bayer-cropscience-extend-their-partnership-to-improve-crops-by-gene-editing/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-premiere-administration-de-ucart123-chez-lhomme-dans-le-cadre-de-son-etude-clinique-de-phase-i-menee-au-weill-cornell-medicine-newyork-presbyterian-hospital-ciblant-la-leucemie-ai/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-sa-combined-general-shareholders-meeting-of-june-14-2013/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/precision-biosciences-and-cellectis-sa-announce-cross-license-and-settlement-agreement-for-gene-editing-technology/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-nomination-de-rainer-boehm-m-d-et-herve-hoppenot-a-son-conseil-dadministration/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-plant-sciences-ceo-luc-mathis-joins-board-of-directors-of-the-french-association-for-plant-biotechnology-afbv/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-grants-genoway-an-exclusive-sublicense-for-its-homologous-recombination-technology-in-the-field-of-genetically-modified-rodent-models/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/tal-effector-nuclease-the-uspto-issues-a-third-patent-licensed-to-cellectis/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/us-patent-institutions-recognize-the-patentability-of-institut-pasteur-cellectis-early-inventions-on-meganucleases/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/compact-talen-the-next-generation-of-tal-effector-nucleases-the-scientific-journal-nature-communications-publishes-an-innovative-study-on-ultra-precise-compact-talen-mini-dna-cutters/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-and-servier-announce-collaboration-in-allogeneic-cell-therapy-ucart19-to-treat-leukemia-and-5-product-candidates-targeting-solid-tumors/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/tal-effector-nuclease-issuance-by-the-uspto-of-two-new-patents-cellectis-provides-its-customers-talen-product-under-license-of-these-patents-to-easily-achieve-any-genome-engineering-projects/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-the-closing-of-20-5-m-share-capital-increase-subscribed-on-march-24-2014-by-u-s-biotechnology-specialist-institutional-investors/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/david-sourdive-vice-president-of-corporate-development-at-cellectis-has-been-appointed-by-french-foreign-trade-minister-nicole-bricq-to-boost-frances-export-performance-in-the-health-sector/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-receives-20-5-m-in-commitments-in-private-placement-from-u-s-biotechnology-specialist-institutional-investors/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-2012-financial-results/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-2013-financial-results/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-bioresearch-launches-vizucell-cell-lines-for-live-cell-imaging/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/tal-effector-nuclease-the-uspto-issues-a-fourth-patent-licensed-to-cellecti/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/launching-of-cancell-cell-lines-featuring-knock-out-of-the-major-cancer-rel/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-plant-sciences-reports-generation-of-high-oleic-soybean-in-journal-of-plant-biotechnology/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-and-stemgent-partner-to-provide-custom-genome-engineered-ips-cell/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-plant-sciences-reports-improvement-of-oil-content-in-algae/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-appointment-of-pierre-schwich-as-group-cfo/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-and-thermo-fisher-scientific-enter-into-agreements-on-talen-a-leading-gene-editing-technology/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/annual-general-meeting-of-june-26-2017/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellartis-is-partner-in-innovaliv-a-major-multinational-regenerative-medicine-project-funded-by-the-european-commission/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-enters-into-an-agreement-with-cellforcure-for-the-cgmp-manufacturing-of-allogeneic-cart-cells/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-s-a-reports-results-from-annual-general-meeting-held-on-june-26-2017/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reorganizes-its-tools-and-services-business-line-in-partnership-with-caisse-des-depots-by-contributing-ectycells-shares-to-cellectis-bioresearch/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/pfizer-and-cellectis-enter-into-global-strategic-cancer-immunotherapy-colla/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/assemblee-generale-mixte-du-26-juin-2017/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/first-in-human-administration-of-ucart123-in-cellectis-aml-phase-i-clinical-trial-at-weill-cornell-medicine-newyork-presbyterian-hospital/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-plant-sciences-announce-the-finalization-of-the-first-glycosylation-lines-of-their-program/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-ucart19-receives-advanced-therapy-medicinal-product-classification-from-ema/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-a-depose-un-document-denregistrement-en-vue-de-son-projet-dintroduction-en-bourse/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-rainer-boehm-m-d-and-herve-hoppenot-to-board-of-directors/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/axxam-and-cellectis-bioresearch-announce-their-collaboration-to-offer-a-new-generation-of-cell-based-assays/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/resultats-de-lassemblee-generale-mixte-des-actionnaires-de-cellectis-s-a-du-26-juin-2017/ 2026-08-06T09:31:57+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-sells-its-swedish-subsidiary-cellectis-ab-to-the-japanese-company-takara-bio-inc/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reaches-milestone-in-servier-collaboration/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-first-half-2013-financial-results/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/pfizers-stake-in-cellectis-capital-is-welcomed-by-its-shareholders/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-publication-of-an-article-in-cancer-research-on-allogeneic-car-t-cell-immunotherapies/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-bioresearch-launches-compact-talen-the-next-generation-of-tal-effector-nucleases/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-host-rd-analyst-day-on-september-11th-at-le-parker-meridien-ho/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/md-anderson-cancer-center-and-cellectis-announce-a-broad-preclinical-and-clinical-strategic-alliance-in-cancer-immunotherapy/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-an-innovative-anti-cancer-approach/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/individual-shareholder-meeting/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-second-quarter-and-first-half-year-2015-financial-results/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/2012-nobel-laureate-in-medicine-shinya-yamanaka-reaffirms-commitment-to-cira-cellectis-partnership/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/successful-gmp-production-process-for-ucart19/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/the-french-prime-minister-jean-marc-ayrault-accompanied-by-fleur-pellerin-deputy-to-the-french-minister-of-industrial-renewal-visited-on-friday-november-9-2012-cellectis-industrial-platform/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-plant-sciences-inc-publishes-a-study-demonstrating-reduced-acrylamide-in-fried-potatoes/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/ucart19-first-in-man-proof-of-concept-to-be-presented-at-2015-ash-annual-me/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-plant-sciences-inc-locks-early-crispr-intellectual-property-uses/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-third-quarter-and-first-nine-months-2015-financial-result/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-plant-sciences-becomes-calyxt/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/servier-exercises-exclusive-worldwide-licensing-option-with-cellectis-for-ucart19-an-allogeneic-car-t-cell-therapy-for-hematological-malignancies/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-s-a-announces-calyxt-is-new-name-for-its-plant-sciences-subsidia/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-presentation-at-the-34th-annual-j-p-morgan-healthcare-conference-in-san-francisco-january-11-14-2016/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-s-a-to-present-data-on-its-allogeneic-car-t-cell-programs-at-american-society-of-gene-cell-therapy-annual-meeting/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-files-first-clinical-trial-application-for-ucart19-an-allogeneic-gene-edited-car-t-cell-product-for-hematological-malignancies/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-data-on-genome-engineering-for-adoptive-immunotherapy-at-the-american-society-of-clinical-oncology-annual-meeting/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-chief-medical-officer-appointment-to-senior-leadership/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-sa-combined-general-shareholders-meeting-of-may-18-2015/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-a-new-car-architecture-controlling-car-t-cell-functions/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/weill-cornell-medical-college-and-cellectis-announce-research-alliance-advancing-drug-discovery-and-the-translation-of-novel-immunotherapies-in-leukemia/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-enters-into-new-agreement-with-cellforcure-for-the-cgmp-manufacturing-of-ucart123-for-hematological-malignancies/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-data-on-its-allogeneic-car-t-cell-immunotherapy-programs-at-the-european-hematology-association-annual-meeting/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-subsidiary-calyxt-acquires-land-for-new-headquarters-facility/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-first-quarter-2015-financial-results/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-presentation-at-the-cowen-and-company-36th-annual-health-care-conference-in-boston-march-7-9-2016/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-sa-combined-general-shareholders-meeting-of-june-27-2014/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-promising-study-on-next-generation-engineered-allogeneic-car-t-cells/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-fourth-quarter-and-full-year-2015-financial-results/ 2026-08-06T09:31:58+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/appointment-of-mathieu-simon-md-to-the-position-of-senior-vice-president-of-cellectis-group/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-2011-full-year-earnings/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-the-redemption-of-the-bonds-redeemable-into-shares-subscribed-by-the-fsi-and-pierre-bastid-for-a-total-of-50-million/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-announces-presentations-at-upcoming-conferences/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-plant-sciences-announces-the-signature-of-a-strategic-partnership-with-sesvanderhave-in-sugar-beet/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-resultats-du-premier-semestre-2013/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-opens-labs-and-offices-in-manhattan-new-york/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/changes-in-the-groups-scientific-division-and-appointment-of-the-ceo-of-cel/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-bioresearch-lance-compact-talen-la-nouvelle-generation-de-nucleases-effectrices-tal/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-breakthrough-in-fight-against-cancer-at-esgct-congress/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/medicago-and-cellectis-enter-into-research-agreement-to-improve-therapeutic-proteins-using-nuclease-technology/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-stem-cells-est-fier-dannoncer-le-lancement-du-premier-produit-de-type-hepatocyte-derive-de-cellules-souches-ips-humaines/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-extends-its-tal-technology-intellectual-property-portfolio-throug/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-launches-a-partnership-with-total-for-exploratory-research-into-microalgae-based-substitutes-for-oil-products/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/nomination-du-dr-mathieu-simon-au-poste-de-senior-vice-president-du-groupe/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/the-national-institutes-of-health-awarded-a-contract-to-cellectis-bioresearch-inc/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-plant-sciences-and-bayer-cropscience-strengthen-genome-engineerin/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/information-reglementee-relative-a-la-note-amf-n-2010-07/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-bioresearch-inc-wins-a-6-9-million-contract-with-the-national-institutes-of-health-on-ips-cells/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-the-award-of-nobel-prize-in-medicine-to-professor-yamanaka-confirms-the-relevance-of-the-groups-stem-cell-strategy/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-resultats-2011/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/medicago-and-cellectis-successfully-achieve-first-step-in-research-collaboration/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-an-acceleration-of-its-strategic-refocusing-on-therapeutics-and-agrobusiness/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-le-remboursement-en-actions-des-ora-souscrites-par-le-fsi-et-pierre-bastid-pour-un-montant-de-50-millions-deuros/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-results-paving-the-way-for-new-therapeutic-approaches-against-cancer-and-genetic-diseases/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/sceil-a-new-offering-for-the-general-public-to-turn-adult-cells-into-stem-cells-and-store-them/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-plant-sciences-annonce-la-signature-dun-partenariat-strategique-avec-sesvanderhave-pour-ameliorer-la-betterave-sucriere/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-stem-cells-today-announces-the-release-of-a-new-and-improved-user-friendly-format-of-stem-cell-derived-cardiomyocytes/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-group-announces-groundbreaking-in-vivo-proof-of-concept-testing-of-their-flagship-ucart19-product-for-curative-therapy-of-leukemia/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/volutions-au-sein-de-la-direction-scientifique-du-groupe-et-nomination-du-directeur-general-de-cellectis-plant-sciences/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-2012-first-half-earnings/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-sa-shareholders-general-meeting-of-february-16-2015/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/medicago-et-cellectis-annoncent-leur-collaboration-de-recherche-afin-dameliorer-les-proteines-therapeutiques-grace-a-la-technologie-des-nucleases/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-a-step-towards-a-new-therapy-for-aids-cellectis-publishes-genome-engineering-advance-in-nature-methods/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-2014-financial-results/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg http://www.cellectis.com/sites/default/files/en.png https://www.cellectis.com/fr/presse/cellectis-lance-un-partenariat-avec-total-dans-la-recherche-exploratoire-sur-les-substituts-aux-produits-petroliers-a-partir-de-microalgues/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/combined-general-meeting-for-cellectis-shareholders-on-june-22nd-2012/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-prices-initial-public-offering-of-american-depositary-shares/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-plant-sciences-et-bayer-cropscience-renforcent-leur-partenariat-dans-lingenierie-des-genomes/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-stem-cells-today-proudly-announces-the-launch-of-the-worlds-very-first-human-ips-cell-derived-hepatocyte-product/ 2026-08-06T09:31:59+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/sceil-lancement-dune-offre-grand-public-dediee-a-la-transformation-de-cellules-adultes-en-cellules-souches-ips-et-a-leur-stockage/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/precision-biosciences-et-cellectis-sa-ont-conclu-un-accord-transactionnel-et-convenu-de-licences-croisees-portant-sur-une-technologie-dingenierie-des-genomes/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/pfizer-et-cellectis-annoncent-une-collaboration-strategique-mondiale-dans-le-domaine-de-limmunotherapie-contre-le-cancer/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-a-etabli-la-preuve-de-concept-in-vivo-de-son-produit-phare-ucart19-comme-traitement-curatif-de-la-leucemie/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-concede-a-genoway-une-sous-licence-exclusive-sur-sa-technologie-de-recombinaison-homologue-dans-le-domaine-des-rongeurs-animaux-modeles-genetiquement-modifies/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/ucart19-reconnu-comme-medicament-de-therapie-innovante-par-lagence-europeen/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/assemblee-generale-mixte-des-actionnaires-de-cellectis-sa-du-14-juin-2013/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-linstitut-pasteur-ont-ete-reconnus-par-les-offices-de-brevets-americains-comme-les-inventeurs-des-meganucleases/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/assemblee-generale-mixte-des-actionnaires-de-cellectis-sa-du-27-juin-2014/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/luc-mathis-directeur-general-de-cellectis-plant-sciences-rejoint-le-conseil-dadministration-de-lassociation-francaise-des-biotechnologies-vegetales/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-retournement-du-marche-des-outils-et-services-en-2013-perspectives-de-developpement-dans-le-domaine-therapeutique-en-2014/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-cede-sa-filiale-suedoise-cellectis-ab-a-la-societe-japonaise-taka/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/nucleases-effectrices-tal-luspto-delivre-un-troisieme-brevet-licencie-a-cel/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/comptes-semestriels-janvier-juin-2013/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/lentree-de-pfizer-au-capital-de-cellectis-saluee-par-ses-actionnaires/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/compact-talen-la-nouvelle-generation-de-nucleases-effectrices-tal-la-revue-scientifique-nature-communications-publie-une-etude-innovante-sur-les-compact-talen-de-mini-cutteurs-ultra-precis-dadn/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-servier-annoncent-un-accord-de-collaboration-dans-le-domaine-de-la-therapie-cellulaire-allogenique-ucart19-pour-le-traitement-des-leucemies-et-5-candidats-medicaments-ciblant-des-tumeurs/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/nucleases-effectrices-tal-luspto-a-delivre-deux-nouveaux-brevets-a-cellectis-cellectis-offre-a-ses-clients-les-produits-talen-sous-licence-de-ces-deux-brevets-pour-realiser-facilement-tous-projets-din/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-un-placement-prive-de-2052-m-souscrit-aupres-dinvestisseurs-institutionnels-specialises-bases-aux-tats-unis/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/david-sourdive-vice-president-du-developpement-corporate-de-cellectis-a-ete-mandate-par-la-ministre-du-commerce-exterieur-nicole-bricq-afin-dameliorer-les-performances-francaises-a-lexportation-dans-l/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-realisation-definitive-de-laugmentation-de-capital-de-2052-m-souscrite-le-24-mars-2014-par-des-investisseurs-institutionnels-specialises-bases-aux-tats-unis/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-resultats-2012-resultat-operationnel-en-ligne-avec-les-previsions-focalisation-au-service-de-la-strategie-de-croissance-nouvelles-perspectives-de-forte-creation-de-valeur-en-therapeutique/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-confirme-son-eligibilite-au-dispositif-pea-pme/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-bioresearch-lance-les-lignees-cellulaires-vizucell-dediees-a-limagerie-cellulaire/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-resultats-2013/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-bioresearch-lance-les-lignees-cellulaires-cancell-qui-permettent-didentifier-de-nouveaux-medicaments-pour-lutter-contre-le-cancer/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/nucleases-effectrices-tal-luspto-delivre-un-quatrieme-brevet-licencie-a-cel/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-stemgent-sassocient-pour-fournir-un-service-dingenierie-des-genomes-personnalise-applique-aux-cellules-ips/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-plant-sciences-annonce-la-production-de-soja-a-haute-teneur-en-acide-oleique-dans-le-journal-of-plant-biotechnology/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-nomination-de-pierre-schwich-aux-fonctions-de-directeur-financier-groupe/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-plant-sciences-annonce-avoir-reussi-a-accroitre-la-teneur-en-huile-contenue-dans-les-algues/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-reorganise-son-pole-outils-et-services-en-apportant-avec-la-caisse-des-depots-les-titres-dectycell-a-cellectis-bioresearch/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-thermo-fisher-scientific-annoncent-une-serie-daccords-portant-sur-les-talen-la-technologie-cle-de-lingenierie-des-genomes/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/axxam-et-cellectis-bioresearch-annoncent-leur-collaboration-pour-offrir-a-lindustrie-bio-pharmaceutique-une-nouvelle-generation-de-tests-cellulaires/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-accelera-groupe-nerviano-medical-sciences-signent-un-accord-pour-realiser-les-etudes-precliniques-de-ucart19-le-produit-phare-de-cellectis/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-lacceleration-de-son-recentrage-strategique-sur-les-domaines-therapeutique-et-agro-industriel1/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-plant-sciences-et-bayer-cropscience-elargissent-leur-partenariat-dedie-a-lamelioration-des-cultures/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-signe-avec-cellforcure-un-accord-de-production-selon-les-normes-cgmp-pour-fabriquer-des-lymphocytes-cart-allogeniques/ 2026-08-06T09:32:00+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-delivrance-par-luspto-dun-brevet-majeur-sur-lingenierie-des-genomes-induite-par-nucleases/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/weill-cornell-medical-college-et-cellectis-annoncent-une-alliance-de-recherche-visant-la-decouverte-de-medicaments-et-dimmunotherapies-innovantes-contre-la-leucemie/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-envisage-une-introduction-en-bourse-aux-tats-unis/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-sur-ses-programmes-dimmunotherapie-adoptive-fondes-sur-des-cellules-car-t-allogeniques-lors-du-congres-annuel-de-leuropean-hematology-association/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-lohio-state-university-via-lohio-state-innovation-foundation-concluent-un-accord-de-licence-portant-sur-la-technologie-car-ciblant-le-myelome-multiple/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-ses-resultats-financiers-pour-le-premier-trimestre-2015/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/assemblee-generale-mixte-des-actionnaires-de-cellectis-sa-du-16-fevrier-201/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-publication-dune-etude-prometteuse-portant-sur-une-nouvelle-generation-de-cellules-ingenierees-car-t-allogeniques/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-lacceleration-de-son-recentrage-strategique-sur-les-domaines-therapeutique-et-agro-industriel/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-atteint-un-jalon-dans-sa-collaboration-avec-servier/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-un-rd-analyst-day-le-11-septembre-a-lhotel-le-parker-mer/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-le-lancement-de-son-introduction-en-bourse-sur-le-nasdaq-aux-etats-unis-damerique/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-publication-dans-cancer-research-dune-etude-portant-sur-ses-programmes-dimmunotherapie-a-partir-de-cellules-car-t-allogeniques/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-realisation-de-la-vente-de-sa-filiale-suedoise-cellect/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-le-depot-dune-version-modifiee-de-son-document-denregistrement-form-f-1-en-vue-de-son-introduction-en-bourse-sur-le-nasdaq-aux-etats-unis-damerique/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-sur-ses-programmes-dimmunotherapie-fondes-sur-des-cellules-car-t-durant-plusieurs-conferences/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/compte-rendu-rd-analyst-day/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-fixe-les-termes-definitifs-de-son-offre-damerican-depositary-shares-dans-le-cadre-de-son-introduction-en-bourse-sur-le-nasdaq-aux-tats-unis-damerique/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/md-anderson-cancer-center-et-cellectis-concluent-une-vaste-alliance-preclinique-et-clinique-en-immunotherapie-contre-le-cancer/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/rencontre-actionnaires-individuels/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-interviendra-a-loccasion-de-plusieurs-conferences/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-deuxieme-trimestre-et-du-premi/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-resultats-du-premier-semestre-2014/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-plant-sciences-publie-une-etude-demontrant-la-reduction-de-la-formation-dacrylamide-dans-les-pommes-de-terre/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-interviendra-a-loccasion-de-plusieurs-conferences1/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/rencontre-actionnaires-individuels1/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-plant-sciences-acquiert-des-droits-de-propriete-intellectuelle-sur-la-technologie-crispr-appliquee-aux-plantes/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/implementation-reussie-du-processus-de-production-de-ucart19-selon-les-bonnes-pratiques-de-fabrication-bpf/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/compte-rendu-rencontre-actionnaires-individuels-du-23-octobre-2014/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-confirme-son-eligibilite-au-dispositif-pea-pme1/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/technologie-talentm-delivrance-du-brevet-ep-2-510-096-par-loffice-europeen-des-brevets/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-plant-sciences-inc-filiale-de-cellectis-s-a-change-de-nom-et-de/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/lexercice-des-bsa-a-rapporte-a-cellectis-13-millions-deuros-de-recettes/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-s-a-presentera-des-donnees-sur-ses-programmes-dimmunotherapie-fondes-sur-des-cellules-car-t-allogeniques-lors-de-la-conference-annuelle-de-lamerican-society-of-gene-cell-therapy/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-trois-presentations-orales-lors-du-56e-congres-annuel-de-lamerican-society-of-hematology-ash/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-s-a-presentera-des-donnees-sur-ses-programmes-dimmunotherapie-adoptive-fondes-sur-des-cellules-car-t-allogeniques-lors-de-la-conference-annuelle-de-lamerican-society-of-clinical-oncology/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-plant-sciences-et-la-fondation-2blades-ont-conclu-un-accord-de-licence-croisee-sur-les-nucleases-effectrices-tal/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/assemblee-generale-mixte-des-actionnaires-de-cellectis-sa-du-18-mai-2015/ 2026-08-06T09:32:01+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-at-the-leerink-partners-6th-annual-global-healthcare-conference-on-thursday-february-16-2017-at-130pm-et-in-new-york/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-a-soumis-une-demande-dessai-clinique-pour-ucart19-un-produit-allogenique-fonde-sur-des-cellules-car-t-ciblant-les-tumeurs-hematologiques/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-delivrance-par-luspto-du-brevet-u-s-9458439-qui-sajou/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-nomination-dune-directrice-medicale/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-a-organise-le-1er-diner-issu-de-ledition-du-genome-a-new-york/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-signe-avec-cellforcure-un-accord-de-production-de-lots-cliniques-de-produit-candidat-ucart123-ciblant-des-tumeurs-hematologiques/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-announces-two-oral-presentations-and-one-poster-at-the-2016/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-filiale-de-cellectis-acquiert-un-terrain-pour-y-installer-son-siege/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-avoir-realise-avec-succes-les-campagnes-de-production-de-son-second-produit-candidat-ucart123-selon-les-bonnes-pratiques-de-fabrication-bpf/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-announces-presentation-at-the-cowen-and-company-36th-annual-health-care-conference-in-boston-march-7-9-2016-en/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-to-participate-in-oppenheimer-life-sciences-summit-ny-in-pip/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-quatrieme-trimestre-et-de-lexe/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-troisieme-trimestre-2016-et-de/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-mabquest-annoncent-un-partenariat-en-immunotherapie-concernant-une-nouvelle-classe-danticorps-monoclonaux-anti-pd-1/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/recommandation-favorable-a-lunanimite-du-rac-concernant-les-protocoles-detude-clinique-de-phase-i-des-programmes-ucart123-ciblant-la-leucemie-aigue-myeloblastique-lam-et-la-leucemie-a-cellules-dendrit/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-takara-bio-inc-concluent-un-accord-de-licence-et-dapprovision/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-une-conference-telephonique-suite-a-la-presentation-faite-aupres-du-comite-consultatif-sur-ladn-recombinant-rac/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-to-present-data-on-its-allogeneic-car-t-cell-programs-at-the-19th-american-society-of-gene-cell-therapy-annual-meeting-en/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-a-soumis-une-demande-dessais-cliniques-pour-ucart123-un-produit-allogenique-fonde-sur-des-cellules-cart-ingenierees-ciblant-des-tumeurs-hematologiques-lam-et-lpdc/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-premier-trimestre-2016/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-participera-a-la-35e-conference-annuelle-healthcare-de-j-p-morgan-avec-une-presentation-le-9-janvier-2017/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/resultats-de-lassemblee-generale-mixte-des-actionnaires-de-cellectis-s-a-d/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/quatre-eminents-specialistes-integrent-le-conseil-scientifique-de-cellectis/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-to-present-data-on-its-allogeneic-car-t-cell-immunotherapy-product-candidates-during-the-upcoming-ash-annual-meeting/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-quun-premier-patient-a-ete-traite-dans-le-cadre-de-letude-clinique-de-phase-1-visant-a-tester-ucart19-dans-le-traitement-de-la-leucemie-aigue-lymphoblastique-a-cellules-b-de-lenfant/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/la-fda-autorise-lentree-en-developpement-clinique-ducart123-le-candidat-medicament-car-t-allogenique-sur-etagere-de-cellectis-ciblant-des-tumeurs-hematologiques-lam-et-lpdc/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-troisieme-trimestre-et-pour-les-neuf-premiers-mois-de-2015/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-named-2016-technology-pioneer-by-the-world-economic-forum-en/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-participera-a-la-6eme-conference-annuelle-global-healthcare-de-leerink-partners-avec-une-presentation-le-16-fevrier-2017-a-13h30-a-new-york/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/servier-exerce-son-option-de-licence-exclusive-et-mondiale-conclue-avec-cellectis-pour-ucart19-une-therapie-allogenique-fondee-sur-des-cellules-car-t-ciblant-les-tumeurs-hematologiques/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/mit-technology-review-names-cellectis-on-annual-list-of-50-smartest-companies-for-second-consecutive-year-en/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-announces-conference-call-to-discuss-ucart19-development-collaboration-with-pfizer-and-servier-en/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-deuxieme-trimestre-2016-et-du/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/fda-grants-cellectis-ind-approval-to-proceed-with-the-clinical-development-of-ucart123-the-first-gene-edited-off-the-shelf-car-t-cell-product-candidate-developed-in-the-u-s/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-announces-presentation-at-the-34th-annual-j-p-morgan-healthcare-conference-in-san-francisco-january-11-14-2016-en/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-wins-2016-most-innovative-european-biotech-sme-award-for-hea/ 2026-08-06T09:32:02+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-launch-of-follow-on-offering/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-participera-a-la-36e-conference-annuelle-healthcare-de-j-p-morgan-avec-une-presentation-le-8-janvier-2018/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-4th-quarter-and-full-year-2016-financial-results/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-pricing-of-follow-on-offering/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/allogene-therapeutics-completes-agreement-for-pfizers-allogeneic-car-t-immuno-oncology-portfolio/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-obtient-deux-brevets-americains-couvrant-lutilisation-de-crispr-dans-les-cellules-t/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/five-additional-leading-physicians-to-join-cellectis-clinical-advisory-boar/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-data-at-the-2018-aacr-annual-meeting/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/servier-et-pfizer-presenteront-les-resultats-des-etudes-chez-lhomme-ducart19-lors-du-44e-congres-annuel-de-lebmt-european-society-for-blood-and-marrow-transplantation/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/servier-and-pfizer-announce-fda-clearance-of-ind-application-for-ucart19-in-adult-relapsed-refractory-acute-lymphoblastic-leukemia/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/harvards-wyss-institute-partners-with-cellectis-to-recode-the-human-genome/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-quatrieme-trimestre-2017-et-de-lexercice-2017/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/shareholders-general-meeting-of-june-26-2018/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/depart-a-la-retraite-de-mathieu-simon-directeur-des-operations-elsy-boglioli-est-nommee-directrice-des-operations/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-3rd-quarter-and-first-nine-months-2016/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-allogene-therapeutics-entendent-poursuivre-la-collaboration-strategique-initiee-avec-pfizer-dans-le-domaine-de-limmunotherapie-contre-le-cancer-pour-accelerer-le-developpement-et-la-comme/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-the-issuance-of-u-s-patent-9458439-following-u-s-patent-8921332-issued-in-december-20141/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-le-lancement-dune-nouvelle-offre-dads/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-data-on-its-car-t-cell-immunotherapy-programs-during-upcoming-conferences1/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-les-modalites-definitives-de-son-offre-dads/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-the-closing-of-the-sale-of-its-swedish-subsidiary-cellectis-ab-to-takara-bio-inc1/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-a-la-conference-annuelle-de-lamerican-association-for-cancer-researchaacr/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-and-accelera-nerviano-medical-sciences-group-sign-an-agreement-to-complete-preclinical-studies-of-cellectis-lead-product-candidate-ucart191/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/linstitut-wyss-de-harvard-sassocie-a-cellectis-pour-reecrire-le-genome-humain/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-at-the-36th-annual-j-p-morgan-healthcare-conference-on-monday-january-8-2018-at-1200pm-pt/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/two-issued-u-s-patents-granted-to-cellectis-for-crispr-use-in-t-cells/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/servier-and-pfizer-announce-results-of-ucart19-first-in-human-trials-to-be-presented-at-the-44th-ebmt-european-society-for-blood-and-marrow-transplantation-annual-meeting/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-4th-quarter-and-full-year-2017-financial-results/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-quatrieme-trimestre-2016/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/dr-mathieu-simon-to-retire-as-cellectis-chief-operating-officer-elsy-boglioli-named-as-successor/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cinq-eminents-experts-rejoignent-le-conseil-scientifique-de-cellectis/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/allogene-therapeutics-a-finalise-laccord-relatif-au-portefeuille-dimmunotherapies-car-t-allogeniques-de-pfizer/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-and-allogene-therapeutics-intend-to-continue-strategic-cancer-immunotherapy-collaboration-to-accelerate-development-and-commercialization-of-allogeneic-off-the-shelf-car-t-therapies/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/servier-et-pfizer-annoncent-lobtention-de-la-part-de-la-fda-de-lautorisation-de-mener-aux-etats-unis-le-developpement-clinique-precoce-de-ucart-19-dans-le-traitement-des-leucemies-lymphoblastiques-aig/ 2026-08-06T09:32:03+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-les-comptes-consolides-pour-lexercice-2014/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg http://www.cellectis.com/sites/default/files/tableau_fr_0.png https://www.cellectis.com/fr/presse/cellectis-annonce-le-depot-dun-document-denregistrement-form-f-1-en-vue-de-son-projet-dintroduction-en-bourse-au-nasdaq-aux-tats-unis/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-plant-sciences-franchit-un-nouveau-jalon-de-son-contrat-avec-medicago-pour-lamelioration-des-proteines-therapeutiques-issues-des-feuilles-de-tabac1/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-suspension-des-etudes-cliniques-de-ucart123/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-files-ind-for-ucart22-in-acute-lymphoblastic-leukemia-b-all1/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-to-participate-in-upcoming-investor-conferences-en/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/un-brevet-couvrant-largement-les-technologies-dedition-du-genome-dont-cellectis-a-une-licence-exclusive-a-ete-maintenu-par-luspto-au-terme-dun-reexamen/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-1st-quarter-2018-financial-results/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/mathieu-simon-m-d-vice-president-executif-et-directeur-des-operations-de-cellectis-occupe-les-fonctions-de-directeur-medical-par-interim/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-annonce-le-lancement-de-son-introduction-en-bourse-sur-le-nasdaq-pour-un-montant-total-denviron-100-millions-de-dollars/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-at-the-2017-annual-conference-of-the-american-association-for-cancer-research1/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-deux-presentations-orales-et-un-poster-lors-du-congres-annuel-de-lamerican-society-of-hematology-ash/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-participate-in-upcoming-investor-conferences/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-announces-proposed-initial-public-offering-of-100-0-million/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/servier-et-pfizer-annoncent-que-les-resultats-preliminaires-des-premieres-etudes-ducart19-chez-lhomme-seront-presentes-lors-du-59e-congres-annuel-de-lamerican-society-of-hematology-ash1/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/mathieu-simon-m-d-cellectis-evp-chief-operating-officer-to-serve-as-interim-chief-medical-officer/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/la-food-and-drug-administration-fda-aux-etats-unis-a-leve-lavis-de-suspension-pour-les-deux-essais-cliniques-de-phase-i-du-produit-candidat-ucart123-ciblant-la-lam-et-la-lpdc/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/servier-and-pfizer-announce-preliminary-results-of-the-first-in-human-trials-of-ucart19-will-be-presented-at-the-59th-american-society-of-hematology-ash-annual-meeting/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-troisieme-trimestre-2017-et-des-neuf-premiers-mois-de-lannee-2017/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-two-oral-presentations-and-one-poster-presentation-at-the-2017-ash-annual-meeting/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-a-soumis-une-demande-dessai-clinique-pour-ucart22-en-leucemie-lymphoblastique-aigue-a-cellules-b/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-a-demontre-comment-la-specificite-de-ledition-du-genome-ciblee-avec-la-technologie-talen-peut-etre-affinee-pour-ameliorer-limmunotherapie-par-transfert-adoptif-de-lymphocytes-t/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/fda-lifts-clinical-hold-on-cellectis-phase-1-clinical-trials-with-ucart123-in-aml-and-bpdcn/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-une-etude-portant-sur-la-securite-dune-nouvelle-architecture-de-car-permettant-de-controler-les-fonctions-des-cellules-car-t/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-third-quarter-and-first-nine-months-of-2017/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/bilan-semestriel-du-contrat-de-liquidite-cellectis-contracte-avec-natixis/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-demonstrates-fine-and-predictable-tuning-of-talen-gene-editing-targeting-to-improve-t-cell-adoptive-immunotherapy/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-clinical-hold-of-ucart123-studies/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/bilan-semestriel-du-contrat-de-liquidite-cellectis-contracte-avec-la-societe-natixis/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-a-elabore-une-nouvelle-architecture-de-car-permettant-de-controler-les-fonctions-des-cellules-car-t1/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/ucart19-premiere-preuve-de-concept-chez-lhumain-presentee-lors-de-la-prochaine-conference-annuelle-de-lamerican-society-of-hematology1/ 2026-08-06T09:32:04+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/preliminary-data-from-servier-and-pfizers-ucart19-product-candidate-shows-high-complete-remission-rate-across-two-phase-i-adult-and-pediatric-acute-lymphoblastic-leukemia-trials/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-premier-trimestre-2018/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/assemblee-generale-mixte-du-26-juin-2018/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-closing-of-follow-on-offering/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-ceo-selected-as-speaker-for-2017-milken-institute-global-conference-en/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-novel-methods-to-improve-the-clinical-use-of-chimeric-antigen-receptor-t-cell-therapy-in-scientific-reports/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-premier-trimestre-2017/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-ceo-selected-as-speaker-for-2017-milken-institute-global-conference/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-1st-quarter-2017-financial-results/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-patent-encompassing-broad-uses-of-gene-editing-technologies-maintained-by-uspto/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-annonce-la-fixation-du-prix-de-loffre-realisee-dans-le-cadre-de-son-introduction-en-bourse-dun-montant-total-de-56-millions-de-dollars/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-obtient-un-brevet-couvrant-lutilisation-de-la-technologie-crispr-dans-les-cellules-t/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-announces-pricing-of-56-0-million-initial-public-offering/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-annonce-lexercice-en-totalite-de-loption-de-surallocation-et-la-realisation-definitive-de-son-introduction-en-bourse/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-granted-patent-for-crispr-use-in-t-cells/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-deuxieme-trimestre-2017-et-des-six-premiers-mois-de-lannee-2017/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-announces-full-exercise-of-over-allotment-option-and-closing-of-its-initial-public-offering/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-2nd-quarter-and-first-six-months-2017/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-nomme-elsy-boglioli-au-poste-de-vice-presidente-executive-strategie-et-developpement-corporate/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-dans-scientific-reports-de-nouvelles-techniques-pour-ameliorer-lutilisation-clinique-des-therapies-fondees-sur-les-cellules-car-t/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-nomme-stephane-depil-un-expert-en-immuno-oncologie-au-poste-de-vice-president-senior-de-la-recherche-et-du-developpement-et-directeur-medical/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-s-a-envisage-une-potentielle-introduction-en-bourse-pour-calyxt-inc/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/servier-et-pfizer-publient-des-resultats-preliminaires-de-deux-essais-cliniques-de-phase-i-indiquant-un-taux-eleve-de-remission-complete-obtenus-avec-ucart19-dans-le-traitement-de-la-leucemie-aigue-ly/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-elsy-boglioli-to-executive-vice-president-strategy-and-corporate-development/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-s-a-to-explore-possible-initial-public-offering-of-calyxt-inc/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-immuno-oncology-leader-stephane-depil-to-position-of-senior-vice-president-research-development-and-chief-medical-officer/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-files-registration-statement-for-proposed-initial-public-offering/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-realisation-de-son-offre-dads/ 2026-08-06T09:32:05+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-data-at-the-2018-asgct-annual-meeting/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-updated-clinical-and-translational-data-on-balli-01-at-the-european-hematology-association-eha-2023/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-annonce-lexercice-integral-de-loption-de-surallocation-consentie-aux-banques-en-charge-du-placement/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-announces-launch-of-proposed-follow-on-offering/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-annonce-la-realisation-de-son-offre-secondaire-dactions-pour-un-total-de-609-millions-de-dollars/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-announces-upsizing-and-pricing-of-follow-on-offering/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/acceleration-du-developpement-clinique-ducart123-en-lam-suite-a-lapprobation-dun-protocole-modifie/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-announces-full-exercise-of-underwriters-option-to-purchase-additional-shares/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/la-fda-autorise-lessai-clinique-pour-ucart22-en-leucemie-lymphoblastique-aigue-a-cellules-b/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-announces-successful-closing-of-60-9-million-public-offering/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/resultats-de-lassemblee-generale-mixte-des-actionnaires-de-cellectis-s-a-du-26-juin-2018/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/approval-of-ucart123-amendment-in-aml-to-accelerate-clinical-development/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-deuxieme-trimestre-2018-et-des-six-premiers-mois-de-lannee-2018/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/fda-grants-cellectis-ind-approval-for-ucart22-in-b-all/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-nomme-stefan-scherer-m-d-ph-d-vice-president-senior-du-developpement-clinique-et-directeur-medical-adjoint/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-s-a-reports-results-from-annual-general-meeting-held-on-june-26-2018/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-nomme-dr-yves-ribeill-expert-chevronne-de-lindustrie-des-biotechnologies-et-membre-du-conseil-dadministration-au-poste-de-directeur-general-par-interim/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-2nd-quarter-and-first-six-months-2018/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-nomme-jim-blome-ancien-president-directeur-general-de-bayer-cropscience-lp-au-poste-de-directeur-general/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-stefan-scherer-m-d-ph-d-as-senior-vice-president-clinical-development-and-deputy-chief-medical-officer/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/le-dr-stephan-a-grupp-pionnier-des-car-t-rejoint-le-conseil-scientifique-de-cellectis/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-names-biotech-veteran-and-board-of-directors-member-dr-yves-j-ribeill-as-interim-ceo/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-premiere-administration-de-ucart123-chez-un-patient-atteint-de-leucemie-a-cellules-dendritiques-plasmacytoides-dans-le-cadre-de-son-etude-clinique-de-phase-i-menee-au-md-anderson/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-troisieme-trimestre-2018-et-des-neuf-mois-de-lannee-2018/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-appoints-ceo-jim-blome-former-president-ceo-of-bayer-cropscience-lp/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-ucart123-administered-to-first-patient-with-bpdcn-in-phase-i-clinical-trial-at-md-anderson-cancer-center/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/car-t-pioneer-dr-stephan-a-grupp-to-join-cellectis-clinical-advisory-board/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-3rd-quarter-and-first-nine-months-2018/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-a-la-conference-annuelle-de-lamerican-society-of-gene-cell-therapy-asgct/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-william-monteith-as-senior-vice-president-u-s-manufacturing/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-annonce-le-lancement-dune-offre-secondaire-dactions/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-annonce-laugmentation-du-nombre-dactions-emises-et-la-fixation-du-prix-de-loffre-realisee-dans-le-cadre-de-son-offre-secondaire-dactions/ 2026-08-06T09:32:06+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-sur-ses-programmes-allogeniques-innovants-a-la-conference-annuelle-de-lasgct/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-enters-lease-agreement-to-build-manufacturing-facility-advancing-towards-commercialization-of-its-ucart-portfolio/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-premier-trimestre-2019/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-4th-quarter-and-full-year-2018-financial-results/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/resultats-de-lassemblee-generale-mixte-des-actionnaires-de-cellectis-s-a-du-25-juin-2019/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/fda-clears-the-ind-for-ucartcs1-the-first-allogeneic-car-t-to-treat-multiple-myeloma-patients/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-une-nouvelle-architecture-de-car-visant-a-controler-les-cellules-car-t-sans-les-eliminer/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-oral-and-poster-presentations-of-allogeneic-car-t-cell-programs-at-the-2019-asgct-annual-meeting/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-deuxieme-trimestre-2019-et-des-six-premiers-mois-de-lannee-2019/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-first-quarter-2019/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/le-produit-candidat-sur-etagere-ucartcs1-a-ete-administre-a-un-premier-patient-pour-traiter-le-myelome-multiple-en-rechute-ou-refractaire/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-s-a-reports-results-from-combined-shareholders-meeting-held-on-june-25-2019/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-lonza-signent-un-accord-de-production-cgmp-pour-les-produits-candidats-ucart-allogeniques-de-cellectis/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-new-car-design-to-control-car-t-cells-in-non-lethal-way/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-une-conference-telephonique-pour-presenter-ses-resultats-financiers-du-troisieme-trimestre-2019-et-des-neuf-premiers-mois-de-lannee-2019-le-jeudi-7-novembre-a-14h00-cet/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-second-quarter-and-first-six-months-2019/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-troisieme-trimestre-2019-et-des-neuf-premiers-mois-de-lannee-2019/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/first-patient-dosed-with-off-the-shelf-ucartcs1-product-candidate-for-relapsed-refractory-multiple-myeloma/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/the-institut-pasteur-and-cellectis-extend-exclusive-license-rights-by-granting-genoway-the-authority-to-take-action-against-infringement/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-and-lonza-enter-cgmp-manufacturing-service-agreement-for-cellectis-allogeneic-ucart-product-candidates/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-nomme-william-monteith-en-tant-que-vice-president-senior-u-s-manufacturing/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-hold-third-quarter-and-first-nine-months-2019-earnings-call-on-thursday-november-7-2019-at-800-am-est/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-de-nouvelles-methodes-pour-ameliorer-la-securite-des-traitements-car-t-et-prevenir-le-crs-dans-le-journal-of-biological-chemistry/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-third-quarter-and-first-nine-months-2019/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-conclut-un-contrat-de-location-pour-la-construction-dune-usine-de-production-en-preparation-de-la-commercialisation-de-ses-produits-ucart/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-creation-of-smart-car-t-cells-for-potentially-safer-more-effective-treatments-for-cancer-in-nature-communications/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-quatrieme-trimestre-2018-et-de-lexercice-2018/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-novel-methods-to-improve-the-safety-of-car-t-cell-therapy-and-prevent-crs-in-the-journal-of-biological-chemistry/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/la-fda-autorise-lessai-clinique-pour-ucartcs1-la-premiere-therapie-car-t-allogenique-pour-le-traitement-de-patients-atteints-de-myelome-multiple/ 2026-08-06T09:32:07+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/1st-patient-dosed-with-cellectis-allogeneic-ucart22-in-relapsed-refractory-b-cell-acute-lymphoblastic-leukemia/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-une-conference-telephonique-pour-presenter-ses-resultats-financiers-du-quatrieme-trimestre-2019-et-de-lexercice-2019-le-jeudi-5-mars-a-13h30-cet/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/an-expert-review-on-allogeneic-car-t-for-cancer-published-in-nature-reviews-drug-discovery/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-servier-signent-un-avenant-confirmant-lexpansion-de-leur-collaboration-sur-les-produits-ucart19/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/iovance-biotherapeutics-and-cellectis-enter-into-a-research-collaboration-and-exclusive-worldwide-license-agreement/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-quatrieme-trimestre-2019-et-de-lexercice-2019/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/first-patient-dosed-with-cellectis-new-allogeneic-ucart123-product-candidate-for-relapsed-refractory-acute-myeloid-leukemia/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-nomme-carrie-brownstein-m-d-directrice-medicale/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-and-servier-expand-collaboration-on-ucart19-products/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-une-conference-telephonique-pour-presenter-ses-resultats-financiers-du-premier-trimestre-2020-le-jeudi-7-mai-a-13h30-cet/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-hold-fourth-quarter-and-full-year-2019-earnings-call-on-thursday-march-5-2020-at-730-am-est/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-obtient-un-brevet-aux-etats-unis-couvrant-les-cellules-car-t-allogeniques-ingenierees-avec-crispr-cas9/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-and-servier-execute-the-amendment-confirming-the-expansion-of-their-collaboration-on-ucart19-products/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-premier-trimestre-2020/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-4th-quarter-and-full-year-2019-financial-results/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/lassemblee-generale-mixte-de-cellectis-se-tiendra-a-huis-clos-le-29-juin-2020/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/us-patent-covering-crispr-edited-allogeneic-car-t-cells-granted-to-cellectis/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-nomme-leopold-bertea-expert-chevronne-de-lindustrie-biopharmaceutique-vice-president-senior-des-operations-techniques-europe/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-carrie-brownstein-m-d-as-chief-medical-officer/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-dans-nature-communications-la-creation-de-cellules-car-t-intelligentes-pour-potentiellement-permettre-aux-traitements-anticancereux-detre-plus-surs-et-plus-efficaces/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-une-methode-de-fabrication-simplifiee-pour-generer-des-therapies-cellulaires-car-t-allogeniques-ultra-pures/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-hold-first-quarter-2020-earnings-call-on-thursday-may-7-2020-at-730-am-edt/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-remporte-une-procedure-de-contestation-en-europe-concernant-un-brevet-couvrant-une-methode-dedition-du-genome-utilisant-crispr-cas9-dans-les-cellules-t/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-financial-results-for-first-quarter-2020/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/1ere-administration-ducart22-a-un-patient-ayant-la-leucemie-lymphoblastique-aigue-a-cellules-b-en-rechute-ou-refractaire/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-29-2020/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/des-experts-publient-une-etude-sur-les-car-t-allogeniques-pour-lutter-contre-le-cancer-dans-la-revue-nature-reviews-drug-discovery/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-biopharma-veteran-leopold-bertea-as-senior-vice-president-of-technical-operations-europe/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/iovance-biotherapeutics-et-cellectis-ont-signe-un-partenariat-de-recherche-et-un-accord-de-licence-mondiale-exclusive/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-published-streamlined-manufacturing-method-to-generate-ultrapure-allogeneic-car-t-cell-therapies/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/un-premier-patient-a-recu-une-nouvelle-version-du-produit-candidat-allogenique-ucart123-de-cellectis-pour-traiter-la-leucemie-aigue-myeloblastique-en-rechute-ou-refractaire/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-wins-patent-challenge-in-europe-for-a-method-using-crispr-cas9-for-gene-editing-in-t-cells/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-29-2020/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-servier-etendent-leur-collaboration-sur-les-produits-ucart19/ 2026-08-06T09:32:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-clinical-hold-placed-on-melani-01-study/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-annonce-une-offre-directe-enregistree-aux-etats-unis-de-15-millions-de-dollars/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/to-fully-focus-on-cellectis-dr-andre-choulika-retires-from-calyxts-board-of-directors/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-une-conference-telephonique-pour-presenter-ses-resultats-financiers-du-troisieme-trimestre-2020-le-vendredi-6-novembre-a-14h00-cet/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-biopharma-veteran-steve-doares-ph-d-as-senior-vice-president-site-head-us-manufacturing/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/labstract-selectionne-par-lamerican-society-of-hematology-ash-montre-lactivite-anti-leucemique-initiale-ducart22-dans-lessai-de-phase-i-balli-01-chez-des-patients-adultes-atteints-de-leucemie-lympho-2/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-hold-second-quarter-2020-earnings-call-on-thursday-august-6-2020-at-730am-edt/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-pour-le-troisieme-trimestre-et-pour-les-neuf-premiers-mois-de-lannee-2020/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-financial-results-for-second-quarter-and-first-six-months-2020/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-nomme-kyung-nam-wortman-experte-de-lindustrie-pharmaceutique-vice-presidente-executive-directrice-des-ressources-humaines/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-participate-in-upcoming-investor-conferences1/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/la-fda-autorise-la-reprise-de-lessai-clinique-melani-01-evaluant-le-produit-candidat-ucartcs1-de-cellectis-dans-le-myelome-multiple/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-announces-15-million-registered-direct-offering/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/american-society-of-hematology-ash-cellectis-devoile-des-resultats-preliminaires-de-son-essai-clinique-de-phase-i-balli-01-evaluant-ucart22-chez-ladulte-atteint-de-lla-a-cellules-b-en-rechute-ou-refra/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-hold-third-quarter-2020-earnings-call-on-friday-november-6-2020-at-800am-est/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-le-lancement-dune-nouvelle-offre-dads1/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/american-society-of-hematology-ash-abstract-shows-initial-anti-leukemic-activity-of-ucart22-in-balli-01-phase-1-study-in-r-r-adult-b-all1/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-financial-results-for-third-quarter-and-first-nine-months-2020/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-pharma-hr-leader-kyung-nam-wortman-as-executive-vice-president-chief-human-resources-officer/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/resultats-de-lassemblee-generale-mixte-des-actionnaires-de-cellectis-s-a-du-29-juin-2020/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/fda-lifts-clinical-hold-on-melani-01-study-evaluating-cellectis-product-candidate-ucartcs1-in-multiple-myeloma/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-suspension-de-letude-clinique-melani-01/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-preliminary-results-from-its-phase-1-balli-01-study-of-ucart22-in-r-r-adult-b-all-at-american-society-of-hematology-ash-annual-meeting/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/pour-se-concentrer-pleinement-sur-cellectis-andre-choulika-se-retire-du-conseil-dadministration-de-calyxt/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-launch-of-follow-on-offering1/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-nomme-steve-doares-ph-d-expert-chevronne-de-lindustrie-biopharmaceutique-vice-president-senior-us-manufacturing-directeur-de-site/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-withdrawal-of-follow-on-offering/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-une-conference-telephonique-pour-presenter-ses-resultats-financiers-du-second-trimestre-2020-le-jeudi-6-aout-a-13h30-cet/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-pour-le-deuxieme-trimestre-et-le-premier-semestre-2020/ 2026-08-06T09:32:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-hold-fourth-quarter-2020-earnings-call-on-friday-march-5-2021-at-800am-est/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-sanofi-sassocient-pour-utiliser-lalemtuzumab-en-tant-quagent-lymphodepletant-pour-les-car-t-allogeniques/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-4th-quarter-and-full-year-2020-financial-results/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/resultats-de-lassemblee-generale-mixte-des-actionnaires-de-cellectis-s-a-du-1-juin-20211/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-establishes-an-at-the-market-atm-program-on-nasdaq/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/a-loccasion-des-innovation-days-cellectis-devoile-ses-nouveaux-produits-candidats-en-developpement-sa-plateforme-de-chirurgie-du-genome-heal-ainsi-que-ses-capacites-de-production/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-completes-sale-of-47-million-through-its-atm-program/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-une-conference-telephonique-pour-presenter-ses-resultats-financiers-du-deuxieme-trimestre-2021-le-vendredi-6-aout-a-14h00-cet/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-1-2021/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-pour-le-deuxieme-trimestre-et-le-premier-semestre-2021/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-financial-results-for-first-quarter-2021/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-sa-participation-a-cinq-conferences-investisseurs/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-and-sanofi-partner-on-alemtuzumab-as-lymphodepletion-agent-for-allogeneic-car-t/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-precliniques-sur-lactivite-anti-tumorale-de-son-produit-candidat-ucartmeso-a-la-society-for-immunotherapy-of-cancer-sitc-36th-annual-meeting/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-1-20211/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-innovation-days-event-highlighted-new-product-development-new-genome-surgery-platform-heal-and-manufacturing-capabilities/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-le-retrait-de-son-offre-dads/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-hold-second-quarter-2021-earnings-call-on-friday-august-6-2021-at-8am-edt/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cytovia-therapeutics-et-cellectis-sassocient-pour-developper-des-cellules-nk-derivees-dipsc-genetiquement-modifiees-par-talen/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-financial-results-for-second-quarter-and-first-six-months-2021/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-une-conference-telephonique-pour-presenter-ses-resultats-financiers-du-quatrieme-trimestre-2020-le-vendredi-5-mars-a-14h00-cet/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-participation-in-five-investor-conferences/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-quatrieme-trimestre-2020-et-de-lexercice-2020/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-preclinical-data-on-ucartmeso-supporting-anti-tumor-activity-at-the-society-for-immunotherapy-of-cancer-sitc-36th-annual-meeting/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-met-en-place-un-programme-at-the-market-sur-le-nasdaq/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-realise-un-placement-dadss-pour-47-millions-de-dollars-sur-le-nasdaq-dans-le-cadre-de-son-programme-at-the-market/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/lassemblee-generale-mixte-de-cellectis-se-tiendra-a-huis-clos-le-1-juin-2021/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cytovia-therapeutics-and-cellectis-partner-to-develop-talen-gene-edited-ipsc-derived-natural-killer-cells/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-premier-trimestre-2021/ 2026-08-06T09:32:10+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-financial-results-for-third-quarter-and-first-nine-months-2021/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-nomme-bing-wang-phd-mba-en-tant-que-directeur-financier1/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-first-preclinical-data-on-ucartmeso-an-allogeneic-car-t-cell-product-candidate-targeting-mesothelin-to-treat-solid-tumors-at-the-annual-meeting-of-the-society-for-immunotherapy-of-c/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-annonce-le-placement-dactions-et-de-bons-de-souscriptions-dactions-pour-un-montant-denviron-109-millions-de-dollars-aupres-dun-investisseur-institutionnel/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cytovia-and-cellectis-expand-their-talen-gene-edited-ink-partnership-to-enable-broader-collaboration-in-china/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-une-conference-telephonique-pour-presenter-ses-resultats-financiers-du-quatrieme-trimestre-2021-le-vendredi-4-mars-2022-a-14h00-cet/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-encouraging-clinical-data-from-balli-01-study-in-relapsed-refractory-b-cell-acute-lymphoblastic-leukemia-and-preclinical-data-from-talglobin01-at-the-63rd-american-society-of-hemat-2/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-quatrieme-trimestre-2021-et-de-lexercice-2021-fr/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-objectives-for-2022-and-updates-its-corporate-presentation/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-licensed-partner-allogene-therapeutics-announces-removal-of-fda-clinical-hold-on-their-clinical-trials/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-bing-wang-phd-mba-as-chief-financial-officer1/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-announces-pricing-of-offering-of-common-stock-and-warrants-and-updates-business-and-risk-factor-disclosure/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-a-lesgct-les-premieres-donnees-precliniques-de-deux-nouvelles-therapies-geniques-pour-les-patients-atteints-dimmunodeficience-combinee-severe-rag1-scid-et-du-syndrome-hyper-ige/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-hold-fourth-quarter-2021-earnings-call-on-friday-march-4-2022-at-800am-est/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-une-conference-telephonique-pour-presenter-ses-resultats-financiers-du-troisieme-trimestre-2021-le-vendredi-5-novembre-a-14h00-cet1/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-4th-quarter-and-full-year-2021-financial-results/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/american-society-of-hematology-ash-cellectis-annonce-la-publication-de-deux-abstracts-portant-sur-des-resultats-cliniques-preliminaires-actualises-de-son-essai-balli-01-et-des-premiers-resultats-precl/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-pour-le-troisieme-trimestre-et-pour-les-neuf-premiers-mois-de-lannee-2021/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/society-for-immunotherapy-of-cancer-sitc-cellectis-presente-les-premieres-donnees-precliniques-de-ucartmeso-son-produit-candidat-de-cellules-car-t-allogeniques-ciblant-la-mesotheline-pour-le-traitemen/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-cytovia-etendent-leur-partenariat-en-chine-pour-developper-des-cellules-nk-derivees-dipsc-genetiquement-modifiees-par-talen/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-initial-preclinical-data-on-two-novel-gene-therapies-for-patients-with-rag1-severe-combined-immunodeficiency-scid-and-hyper-ige-syndrome-at-esgct-2021/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/63e-congres-annuel-de-lamerican-society-of-hematology-cellectis-annonce-des-donnees-cliniques-encourageantes-de-letude-balli-01-pour-les-patients-atteints-de-leucemie-aigue-lymphoblastique-a-cellule-2/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-hold-third-quarter-earnings-call-on-friday-november-5-2021-at-8am-edt/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-devoile-ses-objectifs-business-pour-lannee-2022-et-sa-nouvelle-presentation-corporate/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-release-of-abstracts-at-ash-showcasing-updated-preliminary-clinical-data-from-balli-01-study-and-first-preclinical-data-from-talglobin01/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-levee-de-lavis-de-suspension-par-la-fda-des-essais-cliniques-de-son-partenaire-sous-licence-allogene-therapeutics/ 2026-08-06T09:32:11+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-financial-results-for-first-quarter-2022/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-une-conference-telephonique-pour-presenter-ses-resultats-financiers-du-deuxieme-trimestre-2022-le-vendredi-5-aout-a-14h00-cet/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-research-data-on-a-novel-immune-evasive-universal-car-t-cell-at-asgct/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-recoit-laccord-de-la-fda-pour-demarrer-un-essai-clinique-sur-ucart20x22-son-premier-produit-candidat-concu-et-fabrique-en-interne-pour-le-traitement-des-tumeurs-malignes-a-cellules-b/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-28-2022/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-deuxieme-trimestre-2022/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-the-appointment-of-axel-sven-malkomes-dr-donald-a-bergstrom-m-d-ph-d-to-its-board-of-directors/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-sa-participation-a-quatre-conferences-investisseurs-en-septembre/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-28-2022/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-sa-participation-a-deux-conferences-investisseurs/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-article-in-nature-communications-unveiling-novel-immune-evasive-universal-allogeneic-car-t-cells-with-potential-for-improved-persistence/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-les-donnees-precliniques-de-son-premier-produit-candidat-allogenique-a-deux-cars-ucart20x22-pour-les-patients-atteints-de-lymphome-non-hodgkinien-en-rechute-ou-refractaire-lors-du-c/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-second-quarter-2022-financial-results/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-recoit-une-note-convertible-de-20-millions-de-dollars-dans-le-cadre-de-laccord-de-collaboration-avec-son-partenaire-cytovia-therapeutics/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-receives-ind-clearance-for-ucart20x22-its-first-in-house-manufactured-product-candidate-for-the-treatment-of-b-cell-malignancies/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-deux-articles-dans-nature-communications-demontrant-une-validation-preclinique-solide-du-produit-candidat-ucart123-pour-traiter-la-lam-et-le-tcpdb/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-financial-results-for-second-quarter-2022/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-ses-resultats-financiers-pour-le-premier-trimestre-2022/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-participation-in-four-upcoming-investor-conferences-in-september/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-inc-cellectis-majority-owned-subsidiary-reports-its-first-quarter-2022-financial-results1/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-participate-in-two-upcoming-investor-conferences-in-march/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-premier-trimestre-2022/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-preclinical-data-from-its-first-allogeneic-dual-car-t-cell-product-candidate-ucart20x22-for-patients-with-relapsed-or-refractory-non-hodgkin-lymphoma-at-the-american-association-for/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-des-donnees-de-recherche-dune-nouvelle-cellule-car-t-universelle-au-congres-annuel-de-lasgct/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-receives-20-million-convertible-note-under-collaboration-agreement-with-its-partner-cytovia-therapeutics/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/lassemblee-generale-mixte-de-cellectis-se-tiendra-le-28-juin-2022/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-two-articles-in-nature-communications-providing-strong-preclinical-validation-of-ucart123-to-treat-aml-and-bpdcn/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-les-nominations-daxel-sven-malkomes-et-de-donald-a-bergstrom-m-d-ph-d-a-son-conseil-dadministration/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-first-quarter-2022-financial-results/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/resultats-de-lassemblee-generale-mixte-des-actionnaires-de-cellectis-s-a-du-28-juin-20221/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-inc-cellectis-majority-owned-subsidiary-reports-its-first-quarter-2022-financial-results/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-devoile-dans-nature-communications-de-nouvelles-cellules-car-t-universelles-immuno-evasives-dotees-dune-persistance-potentiellement-amelioree/ 2026-08-06T09:32:12+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-pre-clinical-data-on-talen-edited-smart-car-t-cells-overcoming-key-challenges-of-targeting-solid-tumors-at-sitc-2022/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/mayflower-bioventures-lance-sa-premiere-spin-off-primera-therapeutics-en-collaboration-avec-cellectis-pour-developper-une-plateforme-dedition-du-genome-pour-traiter-les-maladies-mitochondriales/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-manuscript-in-frontiers-bioengineering-and-biotechnology-unveiling-efficient-multitool-multiplex-gene-engineering-combining-talen-and-tale-base-editors-tale-be/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-met-en-place-un-programme-at-the-market-sur-le-nasdaq1/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-host-a-live-webcast-and-provide-a-company-update-on-december-13-2022/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-et-cibus-annoncent-la-signature-dun-accord-de-fusion/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-positive-preliminary-clinical-data-for-ucart22-in-all-and-ucart123-in-aml/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-modifie-sa-note-convertible-de-20-millions-de-dollars-dans-le-cadre-de-laccord-de-collaboration-avec-son-partenaire-cytovia-therapeutics/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-first-dosing-of-a-patient-with-its-in-house-manufactured-product-candidate-ucart22-for-the-treatment-of-r-r-b-cell-all/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-nomme-mark-frattini-m-d-ph-d-en-tant-que-directeur-medical/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-secures-a-40-million-credit-facility-from-the-european-investment-bank-to-support-its-research-development-and-innovation-activities/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-precliniques-sur-des-cellules-smart-car-t-editees-par-talen-permettant-un-meilleur-ciblage-des-tumeurs-solides-a-la-reunion-annuelle-de-la-society-for-immunotherapy-of/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/mayflower-bioventures-launches-its-first-spin-out-primera-therapeutics-in-strategic-collaboration-with-cellectis-to-develop-a-gene-editing-platform-to-treat-mitochondrial-diseases/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-des-donnees-sur-deux-programmes-precliniques-de-therapies-geniques-basees-sur-talen-pour-les-patients-atteints-de-drepanocytose-et-de-mucopolysaccharidose-de-type-i-a-lesgct-2022/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-establishes-an-at-the-market-atm-program-on-nasdaq1/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-une-conference-telephonique-pour-presenter-ses-resultats-financiers-du-troisieme-trimestre-2022-le-vendredi-4-novembre-a-14h00-cet/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-and-cibus-announce-the-signing-of-a-definitive-merger-agreement/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-cliniques-sur-ameli-01-et-des-donnees-precliniques-sur-ucartcs1-a-lamerican-society-of-hematology-2022/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-amends-20-million-convertible-note-under-collaboration-agreement-with-its-partner-cytovia-therapeutics/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-pour-le-troisieme-trimestre-et-pour-les-neuf-premiers-mois-de-lannee-2022/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-mark-frattini-m-d-ph-d-as-chief-medical-officer/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-des-donnees-precliniques-sur-des-cellules-smart-car-t-editees-par-talen-pouvant-surmonter-les-principaux-defis-du-ciblage-des-tumeurs-solides-a-la-reunion-annuelle-de-la-society-for/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-pre-clinical-data-on-talen-edited-smart-car-t-cells-supporting-improved-solid-tumor-targeting-at-the-society-for-immunotherapy-of-cancers-sitc-37th-annual-meeting/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-un-article-dans-frontiers-bioengineering-and-biotechnology-sur-une-strategie-de-multiplexage-dingenierie-du-genome-efficace-en-combinant-la-technologie-talen-et-les-base-editor-tale-t/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-data-on-two-talen-based-gene-therapy-preclinical-programs-for-patients-with-sickle-cell-disease-and-mucopolysaccharidosis-type-i-at-esgct-2022/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-un-webcast-en-direct-le-13-decembre-2022/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-third-quarter-2022-financial-results/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-des-donnees-cliniques-preliminaires-positives-pour-ucart22-dans-la-lla-et-ucart123-dans-la-lam/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-showcase-clinical-data-from-ameli-01-and-preclinical-data-from-ucartcs1-at-ash-2022/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-que-son-produit-candidat-ucart22-fabrique-en-interne-a-ete-administre-a-un-premier-patient-pour-le-traitement-de-la-leucemie-lymphoblastique-aiguee/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-financial-results-for-third-quarter-and-first-nine-months-2022/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-obtient-un-credit-dun-montant-de-40-millions-deuros-de-la-banque-europeenne-dinvestissement-pour-accompagner-ses-activites-de-recherche-de-developpement-et-dinnovation/ 2026-08-06T09:32:13+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-fourth-quarter-and-full-year-2022-financial-results/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-ses-resultats-financiers-du-premier-trimestre-le-4-mai-2023/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-poster-presentation-on-talen-edited-muc1-car-t-cells-targeting-triple-negative-breast-cancer-at-the-american-association-of-cancer-research-aacr-annual-meeting/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-une-presentation-orale-sur-son-essai-clinique-ameli-01-et-une-presentation-poster-sur-lingenierie-multiplex-pour-une-production-amelioree-de-cellules-car-t-performantes-au-congres-an/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-enters-into-warrant-agreement-with-the-european-investment-bank-related-to-credit-facility-agreement-and-announces-the-drawdown-of-the-first-tranche-of-20-million/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-dosing-of-the-first-patient-in-europe-with-its-in-house-manufactured-product-candidate-ucart22/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-preclinical-data-on-talen-edited-muc1-car-t-cells-to-enhance-efficacy-in-targeting-triple-negative-breast-cancer-at-the-american-association-for-cancer-research-aacr-annual-meeting/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-le-lancement-dune-nouvelle-offre-dads2/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-implements-clls52-for-the-first-time-in-the-clinic-with-sanofis-alemtuzumab/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-les-modalites-definitives-de-son-offre-dads1/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-first-quarter-2023-financial-results-on-may-4-2023/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-complete-lannonce-des-modalites-definitives-de-son-offre-dads-avec-la-repartition-de-son-capital-apres-la-realisation-de-son-offre-dads/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-oral-presentation-on-ameli-01-and-poster-presentation-on-multiplex-engineering-for-superior-generation-of-car-t-cells-at-the-american-society-of-gene-and-cell-therapy-asgct-annual/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-le-reglement-livraison-de-son-offre-dads-et-lexercice-de-loption-de-surallocation-des-banques-garantes/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-update-and-reports-financial-results-for-first-quarter-2023/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-ses-resultats-financiers-du-quatrieme-trimestre-et-de-lannee-2022-le-8-mars-2023/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/calyxt-inc-reports-its-fourth-quarter-2022-financial-results-and-provides-corporate-update1/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-launch-of-follow-on-offering2/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-quatrieme-trimestre-2022-et-de-lexercice-2022/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-pricing-of-follow-on-offering1/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-un-poster-sur-les-cellules-car-t-muc1-editees-par-talen-ciblant-le-cancer-du-sein-triple-negatif-a-la-reunion-annuelle-de-lamerican-association-of-cancer-research-aacr/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-supplements-the-announcement-of-the-pricing-of-follow-on-offering-with-allocation-of-share-capital-information/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-a-conclu-le-contrat-de-souscription-de-bons-de-souscription-dactions-avec-la-banque-europeenne-dinvestissement-et-annonce-le-tirage-de-la-premiere-tranche-de-20-millions-deuros/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-closing-of-global-offering-and-exercise-of-underwriters-option-to-purchase-additional-shares/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-le-dosage-de-son-premier-patient-en-europe-avec-le-produit-candidat-ucart22-fabrique-en-interne/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-fourth-quarter-and-year-end-2022-financial-results-on-march-8-2023/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/reunion-annuelle-de-lamerican-association-for-cancer-research-aacr-cellectis-presente-des-donnees-precliniques-sur-les-cellules-car-t-muc1-editees-par-talen-avec-une-efficacite-amelioree-dans-le-cibla/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/calyxt-inc-reports-its-fourth-quarter-2022-financial-results-and-provides-corporate-update/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-implemente-clls52-pour-la-premiere-fois-en-clinique-avec-lalemtuzumab-de-sanofi/ 2026-08-06T09:32:14+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-dr-cecile-chartier-ph-d-to-its-board-of-directors/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-et-linstitut-imagine-publient-une-etude-de-preuve-de-concept-dun-candidat-produit-de-chirurgie-genique-pour-traiter-le-syndrome-de-la-phosphoinositide-3-kinase-activee-de-type-1-apds1/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-second-quarter-2023-financial-results-on-august-3-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-precliniques-sur-son-programme-de-therapie-genique-des-hspc-ainsi-quune-analyse-complete-des-tale-be-lors-du-30eme-congres-annuel-de-lesgct/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-updates-and-preliminary-financial-results-for-second-quarter-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-premier-trimestre-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-full-report-for-second-quarter-2023-financial-results/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-presentation-dun-poster-sur-son-essai-clinique-balli-01-a-leuropean-hematology-association-eha-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-pre-clinical-data-on-multi-armored-allogeneic-muc1-car-t-cells-targeting-triple-negative-breast-cancer-at-the-society-for-immunotherapy-of-cancer-sitc-38th-annual-meeting/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-un-article-dans-frontiers-in-immunology-devoilant-des-donnees-precliniques-sur-un-traitement-novateur-dimmunotherapie-cellulaire-car-t-contre-les-tumeurs-solides-riches-en-stroma/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-and-imagine-institute-publish-a-proof-of-concept-study-of-a-gene-surgery-candidate-to-treat-activated-phosphoinositide-3-kinase-syndrome-type-1-apds1/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-des-donnees-cliniques-de-letude-ameli-01-et-des-donnees-precliniques-sur-lingenierie-multiplex-pour-une-production-amelioree-de-cellules-car-t-performantes-a-lasgct-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-pre-clinical-data-on-hspc-gene-therapy-program-and-comprehensive-analysis-of-tale-be-at-the-egcst-30th-annual-congress/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/lassemblee-generale-mixte-de-cellectis-se-tiendra-le-27-juin-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-un-article-dans-cancer-immunology-research-presentant-des-resultats-precliniques-de-la-capacite-du-produit-candidat-ucart20x22-a-cibler-un-large-spectre-de-patients-atteints-de-tumeur/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-a-devoile-des-donnees-precliniques-a-loccasion-dune-presentation-orale-et-deux-presentations-poster-au-29eme-congres-annuel-de-linternational-society-for-cell-gene-therapy-isct-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-poster-presentation-on-balli-01-at-the-european-hematology-association-eha-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-des-donnees-cliniques-et-translationnelles-actualisees-de-son-essai-clinique-balli-01-a-leuropean-hematology-association-eha-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-article-in-frontiers-in-immunology-unveiling-pre-clinical-data-on-a-novel-treatment-paradigm-for-successful-car-t-immunotherapy-against-stroma-rich-solid-tumors/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/resultats-de-lassemblee-generale-mixte-des-actionnaires-de-cellectis-du-27-juin-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-clinical-data-on-ameli-01-and-preclinical-data-on-multiplex-engineering-for-superior-generation-of-car-t-cells-at-asgct-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-nomme-le-docteur-cecile-chartier-ph-d-a-son-conseil-dadministration/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-27-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-ses-resultats-financiers-du-deuxieme-trimestre-2023-le-3-aout-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-an-article-in-cancer-immunology-research-demonstrating-preclinical-evidence-of-ucart20x22-product-candidate-to-target-a-broad-spectrum-of-patients-with-b-cell-malignancies/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-business-et-financiers-preliminaires-du-deuxieme-trimestre-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-showcased-preclinical-data-at-an-oral-presentation-and-two-poster-presentations-at-the-29th-international-society-for-cell-gene-therapy-isct-2023-annual-event/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-le-rapport-complet-des-resultats-financiers-du-deuxieme-trimestre-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-s-a-reports-results-from-annual-shareholders-general-meeting-held-on-june-27-2023/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-precliniques-sur-des-cellules-smart-muc1-car-t-ciblant-le-cancer-du-sein-triple-negatif-a-loccasion-de-la-38eme-reunion-annuelle-de-la-society-for-immunotherapy-of-can/ 2026-08-06T09:32:15+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-two-poster-presentations-on-novel-talen-editing-process-for-gene-correction-and-gene-insertion-in-hspcs-at-the-asgct-annual-meeting/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-nomme-arthur-stril-directeur-financier-par-interim/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-a-novel-intronic-gene-editing-approach-for-the-treatment-of-inborn-metabolic-diseases-by-edited-hspcs/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-novel-talen-editing-processes-enabling-highly-efficient-gene-correction-and-gene-insertion-in-hspcs/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-des-donnees-precliniques-sur-des-cellules-smart-muc1-car-t-ciblant-le-cancer-du-sein-triple-negatif-a-loccasion-de-la-38eme-reunion-annuelle-de-la-society-for-immunotherapy-of-cance/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-the-fourth-quarter-and-full-year-2023/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-une-collaboration-strategique-et-un-accord-dinvestissement-avec-astrazeneca/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-completion-of-the-additional-equity-investment-by-astrazeneca/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-ses-resultats-financiers-du-troisieme-trimestre-2023-le-6-novembre-2023/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-arthur-stril-as-interim-chief-financial-officer/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-preliminaires-de-lessai-nathali-01-et-des-resultats-actualises-de-lessai-balli-01-lors-de-la-65eme-reunion-annuelle-de-la-american-society-of-hematology-ash/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-first-quarter-2024-financial-results-on-may-28-2024/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-troisieme-trimestre-2023/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-pre-clinical-data-on-multi-armored-allogeneic-muc1-car-t-cells-targeting-triple-negative-breast-cancer-at-the-society-for-immunotherapy-of-cancer-sitc-38th-annual-meeting/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-signature-de-laccord-dinvestissement-definitif-avec-astrazeneca/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-strategic-collaboration-and-investment-agreements-with-astrazeneca/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/lassemblee-generale-extraordinaire-de-cellectis-se-tiendra-le-22-decembre-2023/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-third-quarter-2023-financial-results-on-november-6-2023/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/resultats-de-lassemblee-generale-mixte-de-cellectis-du-22-decembre-2023/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-preliminary-results-of-nathali-01-and-updated-results-of-the-balli-01-phases-i-trials-at-the-american-society-of-hematology-ash-65th-annual-meeting/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-le-tirage-de-la-deuxieme-tranche-de-15-millions-deuros-dans-le-cadre-du-contrat-de-credit-conclu-avec-la-banque-europeenne-dinvestissement-la-bei/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-third-quarter-and-first-nine-months-2023/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-deux-posters-sur-un-nouveau-procede-dedition-par-talen-pour-la-correction-et-linsertion-de-genes-dans-les-cellules-souches-et-progenitrices-hematopoietiques-hspcs-a-lasgct/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-the-execution-of-the-subsequent-investment-agreement-with-astrazeneca/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-une-nouvelle-approche-dedition-intronique-pour-le-traitement-des-maladies-metaboliques-congenitales-par-des-cellules-souches-hematopoietiques-modifiees/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-shareholders-meeting-to-be-held-on-december-22-2023/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-de-nouveaux-procedes-deditions-par-talen-permettant-une-insertion-et-une-correction-du-genome-tres-efficaces-dans-les-cellules-souches-progenitrices-et-hematopoietiques-csphs/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-results-from-shareholders-meeting-held-on-december-22-2023/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-quatrieme-trimestre-2023-et-de-lexercice-2023/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-the-drawndown-of-the-second-tranche-of-15-million-under-the-credit-facility-agreement-entered-with-the-european-investment-bank-eib/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-realisation-de-linvestissement-additionnel-dastrazeneca/ 2026-08-06T09:32:16+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-appoints-dr-adrian-kilcoyne-as-chief-medical-officer/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-ses-resultats-financiers-du-troisieme-trimestre-2024-et-une-mise-a-jour-de-ses-activites/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-a-molecular-therapy-article-on-a-smart-dual-car-t-cell-approach-for-treating-recalcitrant-solid-tumors/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publiera-ses-resultats-financiers-du-premier-trimestre-2024-le-28-mai-2024/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-de-multiples-strategies-pour-ameliorer-lefficacite-des-cellules-car-t-dans-les-tumeurs-solides-a-la-reunion-annuelle-de-la-sitc/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-pre-clinical-evidence-of-muc1-car-t-cells-reducing-triple-negative-breast-cancer-while-preserving-safety/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-premier-trimestre-2024/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-data-on-tale-base-editors-and-non-viral-gene-therapy-at-the-esgct-31st-annual-congress/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/l-assemblee-generale-mixte-de-cellectis-se-tiendra-le-28-juin-2024/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-third-quarter-2024-financial-results-on-november-4-2024/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-obtient-la-designation-de-medicament-orphelin-pour-son-produit-car-t-allogenique-ucart22-pour-les-patients-atteints-de-leucemie-lymphoblastique-aigue/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-business-updates-and-financial-results-for-third-quarter-2024/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-devoile-une-approche-de-therapie-genique-non-virale-pour-traiter-la-drepanocytose-dans-nature-communications/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-multiple-strategies-to-enhance-car-t-cell-efficacy-in-solid-tumors-at-the-sitc-annual-meeting/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-un-article-scientifique-devoilant-trois-facteurs-cles-pour-une-edition-efficace-avec-des-tale-base-editors/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-first-quarter-2024/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/resultats-de-lassemblee-generale-mixte-de-cellectis-du-28-juin-2024/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-28-2024/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/la-fda-accorde-le-statut-de-medicament-orphelin-et-medicament-pour-une-maladie-pediatrique-rare-rare-pediatric-disease-designation-rpdd-au-produit-candidat-de-cellectis-ucart22-pour-le-traitement-de-l/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-receives-orphan-drug-designation-for-ucart22-its-allogeneic-car-t-product-for-patients-with-acute-lymphoblastic-leukemia/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/la-fda-accorde-le-statut-de-medicament-orphelin-a-clls52-alemtuzumab-de-cellectis-pour-le-traitement-de-la-lla/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-unveils-a-non-viral-gene-therapy-approach-for-sickle-cell-disease-in-nature-communications/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-deuxieme-trimestre-2024/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-a-scientific-article-unveiling-three-key-factors-for-efficient-tale-base-editing/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-nomme-le-docteur-adrian-kilcoyne-directeur-medical/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-results-from-shareholders-meeting-held-on-june-28-2024/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-un-article-dans-molecular-therapy-sur-la-conception-de-cellules-car-t-pour-le-traitement-de-tumeurs-solides-recalcitrantes/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/fda-grants-orphan-drug-and-rare-pediatric-disease-designation-status-to-cellectis-ucart22-product-candidate-for-acute-lymphoblastic-leukemia-all-treatment/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-des-preuves-precliniques-de-lefficacite-des-cellules-car-t-muc1-contre-le-cancer-du-sein-triple-negatif-tout-en-preservant-la-securite/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/fda-grants-orphan-drug-designation-to-cellectis-clls52-alemtuzumab-for-all-treatment/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-sur-des-tale-base-editors-ainsi-que-sur-son-programme-de-therapie-genique-non-virale-lors-du-31eme-congres-annuel-de-lesgct/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-provides-financial-results-for-the-second-quarter-2024/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publiera-ses-resultats-financiers-du-troisieme-trimestre-2024-le-4-novembre-2024/ 2026-08-06T09:32:17+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-second-quarter-2025-financial-results-on-august-4-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publiera-ses-resultats-financiers-du-troisieme-trimestre-le-7-novembre-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-second-quarter-2025-financial-results-business-updates/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-data-on-non-viral-gene-therapy-and-tale-base-editors-at-the-esgct-annual-congress/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-le-tirage-de-la-troisieme-tranche-de-5-millions-deuros-dans-le-cadre-du-contrat-de-credit-conclu-avec-la-banque-europeenne-dinvestissement-bei/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-hosts-rd-day-today-showcasing-pipeline-progress-and-long-term-value-drivers/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-sa-strategie-smart-car-t-pour-ameliorer-lefficacite-contre-les-tumeurs-solides-a-laacr-io-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-rd-day-highlights-lasme-cels-potential-to-address-significant-unmet-need-for-patients-with-r-r-b-all/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publiera-ses-resultats-financiers-du-quatrieme-trimestre-et-de-lannee-2024-le-13-mars-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-third-quarter-financial-results-on-november-7-20251/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-quatrieme-trimestre-2024-et-de-lexercice-2024-et-une-mise-a-jour-de-ses-activites/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-une-approche-non-virale-dedition-du-genome-et-des-innovations-sur-les-base-editors-a-lasgct-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-the-drawdown-of-the-third-tranche-of-5-million-under-the-credit-facility-agreement-entered-with-the-european-investment-bank-eib/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publiera-ses-resultats-financiers-du-premier-trimestre-le-12-mai-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-smart-car-t-strategy-to-enhance-efficacy-against-solid-tumors-at-aacr-io-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-premier-trimestre-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-13-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/lassemblee-generale-mixte-de-cellectis-se-tiendra-le-26-juin-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-the-fourth-quarter-and-full-year-2024-and-provides-a-business-update/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/resultats-de-lassemblee-generale-mixte-de-cellectis-du-26-juin-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-non-viral-gene-editing-and-base-editing-innovation-at-the-asgct-annual-meeting/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publiera-ses-resultats-financiers-du-deuxieme-trimestre-2025-le-4-aout-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-first-quarter-financial-results-on-may-12-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-deuxieme-trimestre-2025-et-une-mise-a-jour-de-ses-activites/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-the-first-quarter-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-sur-son-programme-de-therapie-genique-non-virale-et-sur-des-tale-base-editors-lors-du-congres-annuel-de-lesgct/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-26-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-aujourdhui-son-rd-day-pour-presenter-les-avancees-de-son-portefeuille-et-ses-perspectives-a-long-terme/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-results-from-shareholders-meeting-held-on-june-26-2025/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/le-rd-day-de-cellectis-souligne-le-potentiel-de-lasme-cel-pour-combler-un-besoin-medical-majeur-non-satisfait-chez-les-patients-atteints-de-lal-b-en-rechute-ou-refractaire/ 2026-08-06T09:32:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-first-quarter-financial-results-on-may-11-2026/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-the-first-quarter-2026/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-de-nouvelles-avancees-sur-eti-cel-lors-du-congres-annuel-de-lash-2025/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-clinical-data-on-lasme-cel-and-eti-cel-at-eha-2026-annual-congress-2/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-troisieme-trimestre-2025-et-une-mise-a-jour-de-ses-activites/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-un-article-dans-nature-communications-sur-un-procede-dedition-genomique-non-viral-efficace-pour-linsertion-genique-dans-les-cellules-souches-hematopoietiques/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-un-webinaire-dedie-aux-actionnaires-francais-le-jeudi-4-decembre-2025/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/ash-2025-cellectis-presente-son-plan-de-developpement-pour-renforcer-les-taux-de-reponse-eleves-obtenus-avec-eti-cel-dans-le-lnh-en-rechute-ou-refractaire/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-present-a-development-update-for-eti-cel-at-ash-2025/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-la-decision-du-tribunal-arbitral-dans-le-litige-lopposant-a-servier/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-third-quarter-2025-financial-results-and-provides-business-update/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-sa-strategie-et-ses-jalons-attendus-en-2026/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-publishes-nature-communications-article-on-a-non-viral-gene-editing-process-enabling-efficient-gene-insertion-in-hematopoietic-stem-cells/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publiera-ses-resultats-financiers-du-quatrieme-trimestre-et-de-lannee-2025-le-19-mars-2026/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/ash-2025-cellectis-presents-development-plan-to-further-enhance-high-response-rate-observed-for-eti-cel-in-r-r-nhl/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-quatrieme-trimestre-2025-et-de-lexercice-2025-et-une-mise-a-jour-de-ses-activites/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-arbitral-decision-in-dispute-with-servier/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/les-donnees-intermediaires-de-lessai-pivot-testant-cema-cel-mettent-en-evidence-la-solidite-de-la-plateforme-car-t-allogenique-de-cellectis1/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-2026-strategy-and-catalysts/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-sa-plateforme-dedition-epigenetique-pour-eteindre-des-genes-sans-modifier-ladn-lors-du-congres-annuel-de-lasgct/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-19-2026/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publiera-ses-resultats-financiers-du-premier-trimestre-le-11-mai-2026/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-full-year-2025-financial-results-and-provides-a-business-update/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-publie-ses-resultats-financiers-du-premier-trimestre-2026/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/les-donnees-intermediaires-de-lessai-pivot-testant-cema-cel-mettent-en-evidence-la-solidite-de-la-plateforme-car-t-allogenique-de-cellectis/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presentera-des-donnees-cliniques-sur-lasme-cel-et-eti-cel-au-congres-annuel-de-leha-2026/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-presents-epigenetic-editing-platform-to-turn-genes-off-without-altering-dna-at-the-asgct-annual-meeting/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/lassemblee-generale-mixte-de-cellectis-se-tiendra-le-le-25-juin-2026/ 2026-08-06T09:32:19+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-recoit-le-statut-rmat-de-la-fda-pour-lasme-cel-la-premiere-therapie-car-t-allogenique-en-essai-pivot-pour-les-patients-atteints-de-lla-b-en-rechute-ou-refractaire/ 2026-08-06T09:32:20+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-les-resultats-finaux-de-phase-1-pour-lasme-cel-et-des-resultats-preliminaires-pour-eti-cel-au-congres-de-leha-2026/ 2026-08-06T09:32:20+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/resultats-de-lassemblee-generale-mixte-de-cellectis-du-25-juin-2026/ 2026-08-06T09:32:20+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-presente-les-resultats-finaux-de-phase-1-pour-lasme-cel-et-des-resultats-preliminaires-pour-eti-cel-au-congres-de-leha-2026/ 2026-08-06T09:32:20+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-results-from-shareholders-meeting-held-on-june-25-2026/ 2026-08-06T09:32:20+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/resultats-de-lassemblee-generale-mixte-de-cellectis-du-25-juin-2026/ 2026-08-06T09:32:20+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-report-second-quarter-financial-results-on-august-6-2026/ 2026-09-07T14:37:18+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-reports-financial-results-for-the-second-quarter-2026/ 2026-09-08T09:07:47+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-participation-in-upcoming-investor-conferences/ 2026-09-08T14:02:35+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-to-host-conference-call-and-webcast-on-september-14-to-provide-a-business-update/ 2026-09-11T15:43:55+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-organise-une-conference-telephonique-et-un-webcast-le-14-septembre-pour-presenter-un-point-dactivite/ 2026-09-11T15:48:08+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/en/press/cellectis-announces-strategic-transformation-to-in-vivo-gene-editing-company/ 2026-09-14T07:19:56+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg https://www.cellectis.com/fr/presse/cellectis-annonce-sa-transformation-strategique-en-societe-dedition-du-genome-in-vivo/ 2026-09-14T07:21:09+00:00 https://www.cellectis.com/wp-content/themes/cellectis/assets/img/banner_default.jpg